Organization Overview
Historical Acquisition Tree
Alternative names
Key: Mitsubishi Tanabe (6) Acquired (9)
acetylsalicylic acid (aspirin) (2 trials)
alteplase (Activase) (2 trials)
Key: Mitsubishi Tanabe (39) Acquired (35)
antihemophilic factor viii human (Hemofil M) (1 trial)
antihemophilic factor viii (Recombinant) (Adynovate) (3 trials)
atorvastatin (lipitor) (1 trial)
autologous adipose-derived mesenchymal stem cells (2 trials)
autologous muscle derived stem cells (2 trials)
bacille calmette-guerin (2 trials)
bepotastine (bepreve) (4 trials)
carbidopa (sinemet) (13 trials)
cariprazine (vraylar) (6 trials)
celecoxib (celebrex) (2 trials)
Coronavirus-Like Particle COVID-19 Vaccine (2 trials)
filgrastim (neupogen) (2 trials)
fingolimod (gilenya) (5 trials)
gemcitabine (gemzar) (1 trial)
golimumab (simponi) (2 trials)
hepatitis b immune globulin (human) (BayHep B) (2 trials)
infliximab (remicade) (7 trials)
influenza vlp vaccine (13 trials)
interferon alpha-2b (Intron-A) (7 trials)
levodopa (larodopa) (11 trials)
macitentan (opsumit) (1 trial)
omeprazole (prilosec) (2 trials)
peginterferon beta-1a (Plegridy) (1 trial)
ribavirin (virazole) (8 trials)
risperidone (risperdal) (3 trials)
roflumilast (daliresp) (4 trials)
sevelamer (renagel) (2 trials)
simvastatin (zocor) (2 trials)
sitagliptin (januvia) (2 trials)
telaprevir (incivek) (11 trials)
tetanus-diphtheria toxoid (1 trial)
ursodeoxycholic acid (1 trial)
Key: Mitsubishi Tanabe (11) Acquired (34)
albumin (Human) (Plasbumin) (1 trial)
aldesleukin (proleukin) (1 trial)
allogeneic natural killer cells (2 trials)
aluminum hydroxide (Gaviscon) (4 trials)
fludarabine (fludara) (1 trial)
fluorouracil (efudex) (1 trial)
fluticasone (cutivate) (1 trial)
haemophilus b conjugate vaccine diphteria crm197 protein conjugate (Menveo) (1 trial)
haemophilus influenzae type b conjugate vaccine (PedvaxHIB) (1 trial)
Key: Mitsubishi Tanabe (11) Acquired (14)
agalsidase beta (fabrazyme) (1 trial)
allogeneic hematopoietic stem cells (Hemacord) (2 trials)
apolipoprotein kringle v (1 trial)
Key: Mitsubishi Tanabe (0) Acquired (10)
Albuminuria (Phase 2)
Alzheimer Disease (Phase 3)
Amyotrophic Lateral Sclerosis (Phase 3)
Anemia (Phase 3)
Angina, Unstable (Phase 2)
Arthritis (Phase 3)
Arthritis, Psoriatic (Phase 3)
Arthritis, Rheumatoid (Phase 3)
Asthma (Phase 3)
Behcet Syndrome (Phase 3)
Brain Ischemia (Phase 3)
Cerebral Infarction (Phase 4)
Colitis (Phase 3)
Colitis, Ulcerative (Phase 3)
Coronary Artery Disease (Phase 2)
Crohn Disease (Phase 3)
Dermatitis (Phase 3)
Dermatitis, Atopic (Phase 3)
Dermatitis, Exfoliative (Phase 3)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Diabetic Nephropathies (Phase 3)
Diabetic Neuropathies (Phase 2)
Diphtheria (Phase 3)
Dyskinesias (Phase 3)
Dyslipidemias (Phase 3)
Endometriosis (Phase 2)
Fatty Liver (Phase 2)
Gastroesophageal Reflux (Phase 3)
Hepatitis (Phase 3)
Hepatitis A (Phase 3)
Hepatitis C (Phase 3)
Hepatitis C, Chronic (Phase 3)
Hepatitis, Chronic (Phase 3)
Hot Flashes (Phase 2)
Hyperlipidemias (Phase 3)
Hyperlipoproteinemias (Phase 3)
Hyperphosphatemia (Phase 3)
Infarction (Phase 4)
Inflammatory Bowel Diseases (Phase 1)
Intestinal Diseases (Phase 1)
Ischemia (Phase 3)
Kidney Diseases (Phase 3)
Liver Diseases (Phase 1)
Lung Diseases (Phase 3)
Lung Diseases, Obstructive (Phase 3)
Lupus Erythematosus, Systemic (Phase 1)
Meningitis (Phase 3)
Meningitis, Bacterial (Phase 3)
Motor Neuron Disease (Phase 3)
Mucocutaneous Lymph Node Syndrome (Phase 3)
Multiple Sclerosis (Phase 2)
Multiple Sclerosis, Relapsing-Remitting (Phase 2)
Muscle Weakness (Phase 3)
Myasthenia Gravis (Phase 3)
Myocardial Infarction (Phase 2)
Non-alcoholic Fatty Liver Disease (Phase 2)
Osteoarthritis (Phase 3)
Osteoarthritis, Hip (Phase 3)
Osteoarthritis, Knee (Phase 3)
Pain (Phase 2)
Peripheral Arterial Disease (Phase 3)
Peripheral Nervous System Diseases (Phase 2)
Peripheral Vascular Diseases (Phase 3)
Poliomyelitis (Phase 3)
Polyneuropathies (Phase 2)
Polyradiculoneuropathy (Phase 3)
Protoporphyria, Erythropoietic (Phase 3)
Psoriasis (Phase 3)
Pulmonary Disease, Chronic Obstructive (Phase 3)
Renal Insufficiency (Phase 1)
Renal Insufficiency, Chronic (Phase 3)
Rhinitis (Phase 3)
Rhinitis, Allergic (Phase 3)
Rhinitis, Allergic, Perennial (Phase 3)
Rhinitis, Allergic, Seasonal (Phase 1)
Schizophrenia (Phase 3)
Scleroderma, Diffuse (Phase 3)
Scleroderma, Systemic (Phase 3)
Sclerosis (Phase 3)
Spinal Cord Injuries (Phase 2)
Stroke (Phase 4)
Tardive Dyskinesia (Phase 3)
Tetanus (Phase 3)
Tetany (Phase 3)
Thrombocytopenia (Phase 3)
Ulcer (Phase 3)
Vascular Diseases (Phase 3)
Whooping Cough (Phase 3)
Wounds and Injuries (Phase 2)
